Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets

L Dai, L Zou, L Meng, G Qiang, M Yan, Z Zhang - Molecular neurobiology, 2021 - Springer
Cholesterol is an indispensable component of the cell membrane and plays vital roles in
critical physiological processes. Brain cholesterol accounts for a large portion of total …

[HTML][HTML] Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment

R Loera-Valencia, J Goikolea… - The Journal of steroid …, 2019 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia and it is characterized by the
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …

The link between Alzheimer disease and metabolic syndrome: a mutual relationship and long rigorous investigation

HM Al-Kuraishy, MS Jabir, AK Albuhadily… - Ageing Research …, 2023 - Elsevier
It has been illustrated that metabolic syndrome (MetS) is associated with Alzheimer disease
(AD) neuropathology. Components of MetS including central obesity, hypertension, insulin …

Role of brain liver X receptor in Parkinson's disease: hidden treasure and emerging opportunities

SA Alnaaim, HM Al-Kuraishy, A Alexiou… - Molecular …, 2024 - Springer
Parkinson's disease (PD) is a neurodegenerative disease due to the degeneration of
dopaminergic neurons (DNs) in the substantia nigra (SN). The liver X receptor (LXR) is …

Current and emerging avenues for Alzheimer's disease drug targets

R Loera‐Valencia, A Cedazo‐Minguez… - Journal of internal …, 2019 - Wiley Online Library
Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a
global epidemic, and so far, there is neither cure nor treatment to alter its progression. The …

Oxidized cholesterol as the driving force behind the development of Alzheimer's disease

P Gamba, G Testa, S Gargiulo, E Staurenghi… - Frontiers in aging …, 2015 - frontiersin.org
Alzheimer's disease (AD), the most common neurodegenerative disorder associated with
dementia, is typified by the pathological accumulation of amyloid Aβ peptides and …

Brain renin–angiotensin system as novel and potential therapeutic target for Alzheimer's disease

R Loera-Valencia, F Eroli, S Garcia-Ptacek… - International journal of …, 2021 - mdpi.com
The activation of the brain renin-angiotensin system (RAS) plays a pivotal role in the
pathophysiology of cognition. While the brain RAS has been studied before in the context of …

Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier

WA Banks - Advanced drug delivery reviews, 2012 - Elsevier
The successful treatment of Alzheimer's disease (AD) will require drugs that can negotiate
the blood–brain barrier (BBB). However, the BBB is not simply a physical barrier, but a …

Oxysterols as biomarkers in neurodegenerative diseases

V Leoni, C Caccia - Chemistry and physics of lipids, 2011 - Elsevier
In the central nervous system cholesterol is involved in membrane structure and function.
Since the blood–brain barrier efficiently prevents cholesterol uptake from the circulation, de …

The controversial role of 24-S-hydroxycholesterol in Alzheimer's disease

P Gamba, S Giannelli, E Staurenghi, G Testa, B Sottero… - Antioxidants, 2021 - mdpi.com
The development of Alzheimer's disease (AD) is influenced by several events, among which
the dysregulation of cholesterol metabolism in the brain plays a major role. Maintenance of …